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 The purpose of this literature review is to evaluate current evidence regarding elevated 
pre-operative hemoglobin A1c levels and its potential effect on post-operative infection risk. 
This case report discussion is a result of completion of an Objective Structured Clinical 
Examination (OSCE) for a patient who presented for a preoperative total knee arthroplasty 
(TKA) evaluation. Research for this literature review was conducted using CINAHL, Pubmed, 
and Google Scholar. Keywords used during this search included “elevated hemoglobin A1c and 
post-operative infection”. Publication dates were limited between 2015 and 2020. A total of 10 
research articles were collected and utilized for this review. The literature that was examined 
revealed conflicting evidence that chronic uncontrolled preoperative hyperglycemia, defined as a 
hemoglobin A1c greater than 8, is associated with poor post-surgical outcomes including 
increased risk for surgical site infection, postoperative wounds, and longer hospital stays.  
Background 
Type 2 diabetes mellitus is a disease caused by insulin resistance in which cells within 
the body no longer respond to insulin. Individuals at risk for type 2 diabetes include those that 
are overweight, over the age of 45, have a family history, poor physical activity, and those of 
African American, Hispanic, American Indian or Alaska Native background. Type 2 diabetes 
can be prevented by appropriate lifestyle changes leading to weight loss reduction through diet 
and exercise (“Type 2 Diabetes”, 2019). According to the Centers for Disease Control (CDC), 
the incidence of type 2 diabetes mellitus is rapidly growing and affects more than 90-95% of 
over 34 million people in the United States that have been diagnosed with diabetes (“Type 2 
Diabetes”, 2019).  
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Individuals with diabetes mellitus are “more likely to require surgery than a person 
without and this is particularly notable for orthopedic surgery” (Akiboye & Rayman, 2017, p. 
12). It is estimated that by 2030, in the United States there will be over 4 million joint 
arthroplasties performed with 8% of these patients having diabetes mellitus (Yang, Sun, Li, & 
Liu, 2017). Diabetes mellitus is a known risk factor for poor postoperative outcomes. Patients 
with diabetes have a 50% higher risk of postsurgical site infection compared to patients without 
diabetes (McCall, 2015). According to Han and Kang (2013), hyperglycemia causes impaired 
phagocytosis and delayed collagen synthesis, thus leading to poor wound healing and increased 
risk of infection. Additionally, anesthesia and surgery can lead to a stress response that releases 
various hormones throughout the body, such as cortisol and glucagon, causing increased insulin 
resistance and elevated glucose levels (Akiboye & Rayman, 2017).  
The success of diabetic treatment can be monitored through hemoglobin A1c testing. 
Hemoglobin A1c is a blood test that is a marker for average blood glucose levels over the 
previous two to three months (Finger, et al., 2017). A diagnosis of type 2 diabetes can be made 
by a hemoglobin A1c greater than 6.5%. According to the American Diabetes Association 
(ADA), for individuals with diabetes the goal hemoglobin A1c is below 7% (“Understanding 
A1C”, n.d.). For surgery, the ADA, Endocrine Society, and the American Association of Clinical 
Endocrinologists (AACE) recommend a peri-operative glucose less that 140mg/dL and a random 
blood glucose less than 180mg/dL (Akiboye & Rayman, 2017). 
In this case report, the patient was seen for a preoperative evaluation and was scheduled 
for a right TKA. She had a diagnosis of controlled type 2 diabetes mellitus with a recent 
hemoglobin A1c level of 8.1 that had been trending upward in comparison to prior visits. She 
recently was non-compliant with her prescription for Victoza, a glucagon-like peptide-1 receptor 
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medication for her type 2 diabetes mellitus. During this visit, her elevated hemoglobin A1c was 
addressed and concerns for an increased risk of postsurgical infection was discussed. This 
literature review will explore evidence-based research concerning elevated pre-operative 
hemoglobin A1c and its potential effect on post-operative infection risk. 
Case Report 
Chief Complaint: Preoperative exam 
HPI: Eileen is a pleasant 57-year-old female who presents to the office today for a preoperative 
consultation at the requirement of Dr. Piatt who plans on performing a right knee arthroplasty 
under general anesthesia on 3/4/20. This will be an outpatient procedure. 
Past medical history: 
Allergies: Amlodipine Besylate (Rash), Cats (Watery eyes, difficult breathing), Environmental 
allergens (Hayfever) 
Medications: 
1. Diclofenac sodium 75 mg delayed-release (enteric coated) tablet. Take 1 tablet (75 mg) 
by mouth 2 times a day 60 tablet. 
2. Fluticasone 50 mcg/spray nasal spray. Spray 1 spray into each nostril 1 time per day 16 g. 
3. Metformin 500 mg extended release tablet. Take 4 tablets by mouth per day.  
4. Acetaminophen 400 mg tablet. Take 1,000 mg by mouth every 4 hours as needed. 
5. Vitamin C 500 MG tablet. Take 1,000 mg by mouth 1 time per day. 
6. Milk thistle-Tumeric capsule. Take 1 capsule by mouth 1 time per day. 
7. Glipizide ER 10 mg extended release tablet (24 hr). Take 1 tablet (10 mg) by mouth 1 
time per day. 
8. Hydrochlorothiazide 25 mg tablet. Take 1 tablet (25 mg) by mouth 1 time per day. 
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9. Lovastatin 10 mg tablet. Take 1 tablet (10 mg) by mouth 1 time per day. 
10. Benazepril 40 mg tablet. Take 1 tablet (40 mg) by mouth 1 time per day. 
11. Multiple Vitamins-Minerals. Take 1 tablet by mouth 1 time per day. 
12. Echinacea C Complete. Take 1 tablet by mouth 1 time per day. 
13. Cinnamon. Take 1 capsule by mouth 1 time per day. 
Medical: 
1. Primary osteoarthritis of both knees 
2. Controlled type 2 diabetes mellitus without complication, without long-term current use 
of insulin  
3. CKD (chronic kidney disease), stage III  
4. Hypercholesterolemia 
5. Essential hypertension 
6. Neuroma of foot 
7. Obstructive sleep apnea of adult 
8. Severe obesity  
9. Hypomagnesemia  
Surgical: 
1. Left total knee arthroplasty 
Family History: Her father had emphysema and her mother had diabetes. Her five siblings 
otherwise have a negative medical history.  
Social History: She is married with two children and currently works at Explore MN tourism. 
She has never smoked or used tobacco. She currently has two alcoholic beverages per week. She 
has no history of drug use.  




General:  Denies fever, chills, night sweats, weight loss/gain or loss of appetite. 
HEENT: Denies blurry vision, dysphagia, sore throat or congestion. 
Neck:  Denies stiffness or pain. 
Respiratory: Denies wheezing, cough, and SOB. 
Cardiovascular:  Denies chest pain, tightness, palpitations, or edema. 
Gastrointestinal: Denies nausea, vomiting, diarrhea, constipation, melena, hematochezia, or 
GERD. 
Genitourinary:  Denies incontinence, hematuria, dysuria, frequency, or urgency. 
Musculoskeletal:  Denies myalgias, arthralgias, or swollen joints. 
Neurologic:  Denies headaches, numbness, or weakness. 
Lymph:  Denies lymphadenopathy. 
Hematology: Denies any bleeding or clotting disorders. 
Psychiatric: Denies anxiety or depression. 
Physical Examination 
Vitals: BP: 136/90 P: 88  
Weight: 168.3 kg (371 lb) 
Body mass index is 53.23 kg/m². 
General: The patient is a pleasant. No acute distress.  
HEENT: Pupils equally round and reactive to light. Extraocular muscles are intact. Conjunctivae 
clear. Tympanic membranes normal with no erythema or bulging. No nasal edema or rhinitis. 
Good dentition with no loose teeth. Uvula midline. Pharynx with no erythema or exudate. 
Neck: Trachea midline. Neck supple. No thyromegaly or thyroid nodules. 
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No supraclavicular or cervical lymphadenopathy. 
Heart: Normal rate, regular rhythm, S1 normal, S2 normal and normal heart sounds. 
Lungs: Clear to auscultation bilaterally with no wheezes or crackles. Effort normal and breath 
sounds normal.   
Abdomen: Soft, nontender, nondistended. No hepatosplenomegaly. No rebound tenderness or 
guarding.  
Musculoskeletal:  Muscle strength is 5 out of 5 of the upper and lower extremities bilaterally.  
Neurological: Cranial nerves II through XII are intact with gross examination. Deep tendon 
reflexes 2+ bilaterally to bicep, tricep, brachioradialis and patellar reflexes. 
Skin:  Skin is warm and dry. No abnormal lesions or rashes present. 
Psychological:  Normal concentration. No active depression or anxiety.  
Labs/Diagnostics 
1. Glucose 229, BUN 21, Creatinine 1.57, otherwise CMP unremarkable 
2. CBC normal 
3. Hemoglobin A1c 8.1 
4. Magnesium normal 
5. EKG normal sinus rhythm 
Surgical risk 
Surgical risk: Intermediate  
History blood clotting or bleeding disorders: No 
Has tolerated anesthesia in the past: Yes 
Postoperative nausea: No 
Pain, stiffness, arthritis of the neck: No 
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Preoperative risk assessment includes:  
1. Cardiovascular status.  
Patient has had no history of ischemia, MI, dysrhythmias, angina or cardiomyopathy. Does have 
history of HTN and HLD, which is controlled on medication. Her exam is unremarkable. 
EKG: Unremarkable 
ACC/AHA Cardiac Risk Factors:  
History of ischemic heart disease: No 
History of compensated or prior heart failure: No 
History of cerebrovascular disease: No 
Diabetes mellitus: Yes 
Renal insufficiency >2: No 
Functional Capacity: 
Some shortness of breath when climbing two flights of stairs. No chest pain.  
2. Pulmonary status.  
Tobacco user: No 
BMI: 53% 
Patient does have a history of sleep apnea and is currently not wearing recommended CPAP at 
night. She has had a previous sleep study. Patient has history of asthma that is well controlled 
without medications. Patient has no history of COPD or other significant cardiorespiratory 
illness. No additional pulmonary assessment indicated. 
3. General Risk/Nutrition 
Gerd: No 
Obesity: Yes 




Hearing impaired/hearing aids: Yes 
Dentures: No 
Dysphagia: No 
3. Infectious risk.  
Patient has no evidence of upper or lower respiratory infection, skin infection, or urinary tract 
infection. However, I do have concerns regarding healing and risk for infection post-surgery due 
to uncontrolled DM. MRSA screen: negative. 
4. Cognitive status. 
Patient has no history of excessive alcohol use, alcohol withdrawal symptoms, or drug use. She 
has no history of contraindications to use of post-operative pain medications or narcotic 
analgesics as needed.  
Assessment 
1. Primary osteoarthritis of both knees 
2. Uncontrolled Type II diabetes 
3. CKD (chronic kidney disease), stage III  
4. Essential Hypertension 
5. Hypercholesteremia 
6. Obstructive Sleep Apnea 
7. Severe Obesity, BMI 53%  
Plan: I discussed with patient that I do not recommend proceeding with her surgery until she has 
better control of her blood sugars as poor blood sugar control is linked with decreased wound 
healing and increased risk of infection after surgery. I will consult with her surgeon regarding my 
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concerns. Keep taking oral diabetic medications. I recommend she start taking Rybelsus once 
daily to help improve glycemic control. Will re-check A1c in 3 months. I would also like her to 
see the diabetic educator. Her kidney function has steadily declined. Stop all NSAIDS to protect 
kidneys. Referral for nephrology. Blood pressures have been well controlled. Continue 
medications as prescribed. Continue medications as prescribed for hypercholesteremia. We 
discussed importance of wearing CPAP at night. We discussed diet modifications. Once blood 
sugars have improved, surgery should help increase exercise which will also help with weight 
management.  
Literature Review 
For diabetic patients undergoing TKA, poor preoperative glycemic control, including a 
hemoglobin A1c greater than 8%, has been linked with a higher risk of postoperative wound 
infections. A retrospective study conducted by Han and Kang (2013), explored 115 patients with 
type 2 diabetes mellitus who underwent a TKA and discovered that the risk of postoperative 
wound infection was correlated with a hemoglobin A1c greater than 8%. While the association 
may not be significant, overall 6.6% of the patients in their study had wound complications. 
They also found that not only was preoperative glycemic control important to decreasing the risk 
of wound infection, operative time was also a factor to be considered. This study suggested that 
surgeons should exercise caution when selecting patients, as well as consider operative time as a 
risk factor for poor outcomes.  
Cancienne, Werner, & Browne (2017) additionally found that as perioperative 
hemoglobin A1c increases, so does the risk of postoperative deep infection requiring surgical 
intervention after TKA. In their cohort study, patients who had a hemoglobin A1c greater than 
8% were more likely to develop an infection within one year after their TKA than those whose 
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hemoglobin A1c levels were less than 8%. While elevated hemoglobin A1c was associated with 
deep postoperative infection after TKA, they did conclude that hemoglobin A1c could not be 
used as an isolated predictor for post-operative infection due to poor sensitivity and intermediate 
specificity. Because of this finding, it is recommended that hemoglobin A1c be considered as a 
reference when assessing risk factors for infection prior to surgery along with other potential risk 
factors (Cancienne, Werner, & Browne, 2017). 
While multiple studies have been outlined that support an elevated hemoglobin A1c 
greater than 8% in diabetic patients undergoing a TKA with an increased risk of post-surgical 
infection, a meta-analysis conducted by Yang, Sun, Li, & Liu (2017) did not find a specific 
optimal threshold for hemoglobin A1c and increased post-surgical joint infection risk. However, 
their meta-analysis of 6 retrospective studies did demonstrate that there was a significantly 
higher risk of periprosthetic joint infections in association to hemoglobin A1c levels, thus 
warranting the screening of hemoglobin A1c to assess deep infection risk prior to surgery.  
Multiple studies outside of TKA procedures have also suggested increased post-operative 
infectious risk in diabetic patients. A prospective, observational pilot study by Chen et al. (2018) 
followed noncardiac surgical patients for one week after their procedure. During the first 7 days 
after surgery, 9 patients with a A1c greater than 7% developed infections including urinary tract 
infections, surgical wound infections, or hospital-acquired pneumonia (Chen, et al., 2018). 
Additionally, they found that patients with a hemoglobin A1c greater than 7% had significantly 
higher variability with their postoperative glucose levels, making postoperative glycemic control 
difficult. Preoperative hemoglobin A1c levels greater than 7% have also been linked with higher 
rates of surgical site infections for individuals undergoing lumbar spinal instrumentation and 
thoracic surgery. Additionally, hemoglobin A1c levels higher than 7% also carry an increased 
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risk of mortality in patients undergoing primary joint arthroplasty (Akiboye & Rayman, 2017). 
Finger et al. (2017) discovered a correlation of increased postoperative infection risk, including 
sepsis, urinary tract infections, and pneumonia, along with increased hospital stay among 
patients undergoing cardiac surgical procedures with a hemoglobin A1c greater than 7%. 
Considering these findings, it is suggested that glycemic control should be optimized before 
scheduling elective surgeries for patients (Chen, et al., 2018).  
One interesting aspect to consider is how hemoglobin A1c screening prior to surgery 
allows for closer monitoring during the perioperative and postoperative period. Jones et al. 
(2014) discuss how elevated hemoglobin A1c before gastrointestinal surgery can help to identify 
patients that are at a higher risk of post-operative hyperglycemia. Post-operative hyperglycemia 
can lead to complications such as increased post-operative infections, increased length of stay, 
and increased mortality among patients. In their observational cohort study, post-operative 
hyperglycemia was linked with hospital readmission, but elevated pre-operative hemoglobin A1c 
was not. They suggest this is the result of the ability of providers to identify these increased risk 
factors through hemoglobin A1c screening prior to gastrointestinal surgery. This led to closer 
glucose monitoring and insulin use post-operatively which decreased infection rates and 
improved outcomes. Glycemic control post-operative was identified as keeping the patient’s 
glucose levels under 250mg/dL as patients with glucose levels greater than 250mg/dL were 20% 
more likely to be readmitted (Jones, et al., 2014).  
Lack of post-operative glycemic control has also been found to increase infectious 
complications in a retrospective study completed by Reátegui et al. (2014). While preoperative 
hemoglobin A1c has been the focus of this case report, it is important to outline the significance 
of post-operative glycemic control and its effect on infectious risk. Both diabetic and non-
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diabetic patients undergoing TKA were examined in their retrospective study and a high rate of 
post-operative complications were found in patients one year after their TKA. Those post-
operative complications included urinary tract infections, wound infection, prosthetic infection, 
phlebitis, and sepsis. Infections were discovered in 11.3% of the 833 patients studied (Reátegui, 
et al., 2014). Despite what other studies have found, in their study they did not find a correlation 
between diabetes mellitus and complications. Rather they discovered that stress-induced 
hyperglycemia as a result of the surgical process led to increased infections regardless of a 
diabetes mellitus diagnosis. Overall, their study concluded that proper post-operative glycemic 
control for all patients, despite a diagnosis of diabetes mellitus, is imperative to reducing post-
operative infections. Contrary to their findings, Finger et al. (2017) determined that while 
hyperglycemia perioperatively was associated with postoperative infections, chronic elevated 
hemoglobin A1c was also a risk factor for postsurgical infections, even with tight perioperative 
glycemic control.  
A retrospective study performed by Underwood et al. (2014) revealed that of all of the 
diabetic patients enrolled, 65% of them did not have a recent A1c measurement within the 
previous 3 months available. This is an area of concern for diabetic patients going into surgery 
because of the known increase risk of poor outcomes and suggests that inadequate glycemic 
control may be occurring during the perioperative period. Due to lack of data, anesthesiologists, 
surgeons, endocrinologists, and internists are using subjective A1c guidelines with some 
surgeons using the ADA recommendation of a hemoglobin A1c less than 7% before performing 
elective surgeries (Underwood, et al., 2014). Underwood et al. (2014) suggest that algorithms 
should be utilized by surgeons and anesthesiologists to help improve glycemic control for 
patients with a hemoglobin A1c greater than 8% so that those individuals that are considered 
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high risk are more easily identified and appropriately treated throughout the preoperative and 
perioperative period.  
Additional risk factors have been identified as an important component for the surgeon to 
consider prior to surgery. Blankush et al., (2016) propose age, wound classification, and surgical 
risk classification as strong indicators of post-surgical infection risk in addition to hemoglobin 
A1c. In their retrospective study, they revealed that elevated pre-operative A1c greater than 7% 
was not an adequate solo indicator of infectious risk post-surgery. However, they did discover 
that hemoglobin A1c did have predictive value for post-operative infection risk when applied to 
certain subgroups within their study. Patients with a preoperative hemoglobin A1c greater than 
8% and a dirty wound had a higher risk for post-operative infection. Also, patients older than 81 
years of age, regardless of wound classification, with a pre-operative hemoglobin A1c greater 
than 7.5% were more likely to suffer a post-operative infection with rates being as high as 1 in 4 
(Blankush, et al., 2016). This study was interesting as it suggested post-operative infection risks 
as complex, with subgroups being affected differently based on the combination of both elevated 
pre-operative hemoglobin A1c levels and other risk factors. Akiboye & Rayman (2017) further 
recommend considering co-morbid conditions, especially for orthopedic surgeries, when 
assessing post-surgical infection risk. Co-morbid conditions include hypertension, obesity, sleep 
apnea, and vascular changes associated with diabetes mellitus. By identifying these risk factors, 
surgeons can more readily assess which subgroups may be at higher risk of post-operative 








• For diabetic patients undergoing TKA, poor preoperative glycemic control, including a 
hemoglobin A1c greater than 8%, is linked with a higher risk of postoperative wound 
infections.  
• Checking a hemoglobin A1c prior to surgery can allow for closer monitoring of 
hyperglycemia in diabetic patients during the preoperative and perioperative period, 
improving postsurgical outcomes. 
• The pre-operative assessment should include a risk assessment of the diabetic patient, 
taking into account their secondary complications due to diabetes and co-morbidities as 
this has been correlated with an increased risk of postoperative complications including 
infection. Medications and glycemia should also be optimized prior to surgery. 
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